KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Intangibles (2016 - 2026)

Teva Pharmaceutical Industries filings provide 18 years of Intangibles readings, the most recent being $3.6 billion for Q1 2026.

  • On a quarterly basis, Intangibles fell 13.85% to $3.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.6 billion, a 13.85% decrease, with the full-year FY2025 number at $3.8 billion, down 14.42% from a year prior.
  • Intangibles hit $3.6 billion in Q1 2026 for Teva Pharmaceutical Industries, down from $3.8 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $7.1 billion in Q1 2022 to a low of $3.6 billion in Q1 2026.
  • Median Intangibles over the past 5 years was $5.1 billion (2024), compared with a mean of $5.2 billion.
  • Biggest five-year swings in Intangibles: fell 18.37% in 2022 and later fell 13.58% in 2023.
  • Teva Pharmaceutical Industries' Intangibles stood at $6.3 billion in 2022, then decreased by 14.08% to $5.4 billion in 2023, then dropped by 17.99% to $4.4 billion in 2024, then dropped by 14.42% to $3.8 billion in 2025, then decreased by 4.55% to $3.6 billion in 2026.
  • The last three reported values for Intangibles were $3.6 billion (Q1 2026), $3.8 billion (Q4 2025), and $3.9 billion (Q3 2025) per Business Quant data.